Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy.

NANot yet recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Cow Milk Protein Allergy
Interventions
OTHER

Test Formula

Hydrolyzed rice protein formula

OTHER

Control Formula

Commercially available extensively hydrolyzed cow's milk formula

Trial Locations (19)

Unknown

Charité Universitätsmedizin Berlin, Berlin

Azienda Ospedaliera Universitaria Federico II, Naples

Azienda Ospedaliero Universitaria di Parma, Parma

AOUP Ospedale Santa Chiara, Pisa

Ospedale Pediatrico Bambino Gesu, Rome

AO Ordine Mauriziano, Turin

Poliklinika Ginekologiczno-Położnicza Arciszewscy, Bialystok

Centrum Medyczne Pratia, Bydgoszcz

IN-VIVO Bydgoszcz, Bydgoszcz

Prywatna Praktyka Lekarska Gabinet Pediatryczno-Alergologiczny, Bydgoszcz

Vitamed Galaj i Cichomski, Bydgoszcz

BioMedical Centers, Janki

Centrum Medyczne Plejady, Krakow

Jagiellonian University Medical College, Krakow

Wojewodzki Szpital Specjalistyczny im. M. Kopernika, Lodz

ETG Lublin, Lublin

Korczowski Bartosz Gabinet Lekarski, Rzeszów

Alergo-Med Specjalistyczna Przychodnia Lekarska, Tarnów

University Hospital of Warsaw, Warsaw

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT06633250 - Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy. | Biotech Hunter | Biotech Hunter